Recently, it was shown that EVs released by patient-derived glioblastoma cells, and carrying Sem3A on their surface, can disrupt brain endothelial barrier function in vivo and in vitro in a NRP1-dependent manner [108], thus highlighting the role of EVs in mediating communication between the BBB and parenchymal cells. The gene discussed is NRP1; the disease is glioblastoma.